Diets compared: what the evidence supports for Mediterranean, low carb, ketogenic, carnivore, and low histamine
Five popular diets, five very different levels of evidence. From the Mediterranean, with a cardiovascular outcome in a randomized trial, to the carnivore, supported by anecdote, a comparison that separates what changes outcomes from what is merely a trend.
The right question is not which diet, but which evidence
Before comparing menus, one must compare the weight of the proof behind each.
A diet's popularity does not measure its evidence. What separates a solid recommendation from a fad is the level of proof: randomized trials with a clinical outcome are worth more than trials with surrogate markers, which in turn are worth more than observational studies, and these more than surveys and personal anecdotes.
Two works anchor the reading of this comparison. In the DIETFITS randomized trial, low-fat and low-carbohydrate diets produced similar weight loss at 12 months, and neither genetic pattern nor insulin secretion predicted who would succeed (Gardner et al., 2018). And in the network meta-analysis of 14 popular dietary programs, the differences between diets were modest and, in large part, disappeared by the end of one year (Ge et al., 2020).
The variable that weighs most is not the name of the diet, it is adherence. The best diet tends to be the one the person can sustain and that serves a defined goal, whether cardiovascular prevention, glycemic control, weight loss, or symptom relief. This text ranks the five diets by evidence, not by trend.
| Level | Example in this text | What it allows one to conclude |
|---|---|---|
| Randomized trial with a clinical outcome | PREDIMED (cardiovascular events) | Probable effect on the outcome that actually matters |
| Randomized trial with a marker | Weight, blood glucose, LDL | Effect on a marker, not necessarily on the final outcome |
| Observational study | Dietary cohorts | Association, not causation |
| Survey or anecdote | Carnivore diet survey | Generates a hypothesis; subject to selection and self-report bias |
Mediterranean: the pattern with an outcome, not just a marker
The only one in the group with a randomized trial on cardiovascular events.
The Mediterranean diet is the one with the strongest proof. In PREDIMED, a randomized primary-prevention trial in thousands of adults at high cardiovascular risk, the Mediterranean pattern supplemented with extra-virgin olive oil or nuts significantly reduced major cardiovascular events compared with the control diet (Estruch et al., 2018). This is the top of the hierarchy: a hard clinical outcome in a randomized design.
The original article was retracted and republished after irregularities in the randomization of some participants were corrected; the main conclusion, of cardiovascular benefit, held in the reanalysis (Estruch et al., 2018). The caveat is worth noting without discarding the finding. In the network meta-analysis, the Mediterranean also figured among the patterns that improve weight and risk factors, with the distinction of having outcome data behind it (Ge et al., 2020).
In practice, the Mediterranean works as a sustainable dietary pattern, based on olive oil, vegetables, legumes, fish, nuts, and whole grains, and not as a restrictive short-term protocol. That is why it serves well as a base, upon which specific goals can be adjusted.
Low carb and ketogenic: tools with an indication
They help with defined metabolic targets, within limits and with monitoring.
It is worth separating the terms. Low carb reduces carbohydrate, commonly to less than 130 g per day. The ketogenic is a stricter subset, generally below 50 g per day, enough to induce ketosis. They are not synonyms, and the intensity of the restriction changes the indication and the cautions.
On weight, the difference from other diets is small. DIETFITS showed no superiority of low-carb over low-fat at 12 months (Gardner et al., 2018), and the meta-analysis of very-low-carbohydrate ketogenic diets found weight loss and improvement in some markers only slightly greater than the low-fat diet over the long term (Bueno et al., 2013).
In type 2 diabetes is where low carb shows its best signal. Goldenberg's meta-analysis found a higher remission rate at 6 months, but the benefit attenuated at 12 months and there were adverse events, which calls for monitoring and not blind enthusiasm (Goldenberg et al., 2021). A continuous-care ketogenic program over 2 years improved glycemic control, but the study was non-randomized and heavily dependent on adherence (Athinarayanan et al., 2019).
The ketogenic still has a consolidated medical indication, distinct from weight loss: refractory epilepsy. Beyond that, the cautions are real: difficult adherence, elevated LDL in subgroups, the initial adaptation malaise, and specific contraindications. Well-conducted low carb is not a carnivore diet, and food quality continues to matter.
| Aspect | Low carb | Ketogenic (very low carbohydrate) |
|---|---|---|
| Carbohydrate | Reduced, commonly < 130 g/day | Very low, < 50 g/day, with ketosis |
| Best evidence | Weight equivalent to low-fat (DIETFITS); T2DM remission at 6 months (Goldenberg) | Slightly greater weight loss over the long term (Bueno); blood glucose in T2DM (Athinarayanan, non-randomized) |
| What it is for | Glycemic control and weight loss with adherence | Selected T2DM; refractory epilepsy (medical use) |
| Caution | Adherence; carbohydrate quality | LDL in subgroups; intense restriction; monitoring |
Carnivore: the one with the least evidence
An interesting signal from anecdote, insufficient basis for a recommendation.
The carnivore diet excludes all foods of plant origin, and with them fiber. The most cited human datum is a survey of 2029 self-selected adults, who reported high satisfaction and some favorable self-reported metabolic markers (Lennerz et al., 2021). This datum must be read for what it is: a survey, with a self-selected sample, self-reported outcomes, without a comparison group and without hard clinical outcomes. The risk of selection and reporting bias is high.
No randomized trial supports the carnivore diet for any outcome. The concerns are concrete: total absence of fiber, very high saturated-fat content with frequent elevation of LDL, potential micronutrient gaps, and unknown long-term safety.
The honest verdict is that the carnivore generates a hypothesis but offers no basis to be recommended as a standard. Self-reported satisfaction and association are not causation, and a marker that improves in the short term does not authorize ignoring unmonitored risks.
Low histamine: a symptomatic approach, not a lifestyle
A targeted clinical trial for histamine intolerance, not a general-health diet.
The low-histamine diet belongs to another category. It does not target weight or metabolism, but rather suspected histamine intolerance, attributed to reduced activity of the enzyme diamine oxidase (DAO), with symptoms such as flushing, headache, digestive complaints, and urticaria (Maintz and Novak, 2007).
Histamine intolerance is real, but difficult to diagnose and probably overdiagnosed. There is no single validated test, and the evidence supporting the diet is limited to small or uncontrolled studies (Comas-Basté et al., 2020). This recommends caution before labeling a patient and restricting their diet for a prolonged period.
The defensible use is as a targeted and temporary trial: an elimination phase followed by guided reintroduction, in selected and symptomatic patients, or when mast cell activation is suspected. Applied broadly and indefinitely, the diet carries a risk of unnecessary restriction, nutrient loss, and food fear, without proven benefit.
Synthesis: the best diet is the one you sustain and that serves the goal
The Mediterranean pattern as a base; the others as tools with an indication and a limit.
Bringing the five together: only the Mediterranean pattern has clinical-outcome evidence in a randomized trial (Estruch et al., 2018); low carb and ketogenic are tools for defined metabolic targets, with monitoring (Goldenberg et al., 2021, Bueno et al., 2013); the carnivore lacks trials (Lennerz et al., 2021); and the low histamine is a targeted clinical trial for suspected intolerance (Comas-Basté et al., 2020).
Above the label, adherence dominates the result, and the differences between reasonable diets shrink over time (Gardner et al., 2018, Ge et al., 2020). That is why the practical question is not which is the best diet in the world, but which is the best diet for this goal, in this person, that they can maintain.
The approach that holds up is simple to state and demanding to apply: define the goal, individualize, diagnose before restricting, and monitor weight, lipids, blood glucose, adherence, and quality of life. No diet is universally best; the worst is the one that does not hold up or the one that trades a marker for a risk that no one is monitoring.
| Diet | Principle | Best level of evidence | What it is for | Cautions | Verdict |
|---|---|---|---|---|---|
| Mediterranean | Dietary pattern (olive oil, vegetables, legumes, fish) | Randomized trial with a cardiovascular outcome (PREDIMED) | Cardiometabolic prevention and a sustainable base | Few; focus on food quality | Recommended base |
| Low carb | Carbohydrate reduction | Weight and blood-glucose trials (markers) | Weight and glycemic control with adherence | Adherence; carbohydrate quality | Tool with an indication |
| Ketogenic | Very low carbohydrate, ketosis | Weight meta-analysis; T2DM (non-randomized portion); epilepsy | Selected T2DM; refractory epilepsy | LDL; intense restriction; monitoring | Tool with an indication |
| Carnivore | Only foods of animal origin | Survey and self-report, no trial | No basis to recommend as a standard | Zero fiber; LDL; micronutrients | Not recommended as a standard |
| Low histamine | Reduction of histamine-rich foods | Limited and small studies | Targeted trial for histamine intolerance | Unnecessary restriction if poorly indicated | Symptomatic and temporary use |
Why this matters for your care
This comparison is part of the library's editorial line: separating what changes outcomes from what is a trend. To think about which approach makes sense in your case, the Functional Self-Assessment helps organize goals and history, and the Library gathers the other notes. Educational content; it does not replace individual medical evaluation, and no diet should be started as treatment without diagnosis and monitoring.
References
- Gardner CD, Trepanowski JF, Del Gobbo LC, et al. Effect of low-fat vs low-carbohydrate diet on 12-month weight loss in overweight adults and the association with genotype pattern or insulin secretion: the DIETFITS randomized clinical trial. JAMA. 2018. doi:10.1001/jama.2018.0245
- Ge L, Sadeghirad B, Ball GDC, et al. Comparison of dietary macronutrient patterns of 14 popular named dietary programmes for weight and cardiovascular risk factor reduction in adults: systematic review and network meta-analysis of randomised trials. BMJ. 2020. doi:10.1136/bmj.m696
- Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. New England Journal of Medicine. 2018. doi:10.1056/NEJMoa1800389
- Bueno NB, de Melo IS, de Oliveira SL, da Rocha Ataide T. Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. British Journal of Nutrition. 2013. doi:10.1017/S0007114513000548
- Goldenberg JZ, Day A, Brinkworth GD, et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ. 2021. doi:10.1136/bmj.m4743
- Athinarayanan SJ, Adams RN, Hallberg SJ, et al. Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical trial. Frontiers in Endocrinology. 2019. doi:10.3389/fendo.2019.00348
- Lennerz BS, Mey JT, Henn OH, Ludwig DS. Behavioral characteristics and self-reported health status among 2029 adults consuming a carnivore diet. Current Developments in Nutrition. 2021. doi:10.1093/cdn/nzab133
- Maintz L, Novak N. Histamine and histamine intolerance. American Journal of Clinical Nutrition. 2007. doi:10.1093/ajcn/85.5.1185
- Comas-Basté O, Sánchez-Pérez S, Veciana-Nogués MT, et al. Histamine intolerance: the current state of the art. Biomolecules. 2020. doi:10.3390/biom10081181
Educational and scientific content. It does not constitute diagnosis, prescription or individual clinical guidance, and does not replace a medical consultation. Management decisions must be individualized by a physician.